PEG shielded MMP sensitive CPPs for efficient and tumor specific gene delivery in vivo.

Area of Science:

• Biotechnology
• Molecular Biology
• Nanomedicine

Background:

• Gene therapy holds promise for treating diseases like cancer.
• Current gene delivery methods using lipoplexes and polyplexes face challenges with in vivo efficacy.
• Targeted delivery of therapeutic genes to tumor cells remains a significant hurdle for clinical translation.

Purpose of the Study:

• To develop a novel method for in vivo plasmid DNA (pDNA) delivery.
• To achieve efficient and tumor-specific gene induction via intravenous administration.
• To overcome the limitations of current gene delivery systems in cancer therapy.

Main Methods:

• Utilized a cell-penetrating peptide (CPP), PepFect14 (PF14), functionalized with polyethylene glycol (PEG) and a matrix metalloprotease (MMP) substrate.
• Formed nanoparticles where pDNA is condensed by CPP and shielded by PEG in an MMP-reversible manner.
• Administered these complexes intravenously for in vivo gene delivery.

Main Results:

• Demonstrated effective nanoparticle formation with CPP and pDNA.
• Showcased MMP-reversible PEG shielding for targeted delivery.
• Achieved efficient gene expression specifically within tumors, sparing normal tissues.

Conclusions:

• The developed delivery vector is a potent platform for tumor-specific gene induction.
• This strategy offers a promising approach to enhance the in vivo efficacy of gene therapy for cancer.
• The MMP-sensitive shielding mechanism facilitates targeted gene delivery and expression in tumors.